Cargando…
The how's and why's of evidence based plasma therapy
Although traditionally fresh frozen plasma (FFP) has been the product of choice for reversing a significant coagulopathy, the modern blood bank will have several different plasma preparations which should all be equally efficacious in reversing a significant coagulopathy or arresting coagulopathic b...
Autor principal: | Yazer, Mark H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983046/ https://www.ncbi.nlm.nih.gov/pubmed/21120202 http://dx.doi.org/10.5045/kjh.2010.45.3.152 |
Ejemplares similares
-
The why and how of sequential and combination therapy in osteoporosis. A review of the current evidence
por: Chandran, Manju
Publicado: (2022) -
Spacer devices for inhaled therapy: why use them, and how?
por: Vincken, Walter, et al.
Publicado: (2018) -
Editorial: Evidence-Based Public Health: Why, What and How
por: Vujcich, Daniel
Publicado: (2017) -
Bacterial Drug Delivery Systems for Cancer Therapy: “Why” and “How”
por: Zhao, Xiangcheng, et al.
Publicado: (2023) -
Platelet Rich Plasma and Orthopedics: Why, When, and How
por: Sánchez, Mikel, et al.
Publicado: (2015)